Makoto Tanikawa

HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics

Toshifumi Tada, Takashi Kumada, Hidenori Toyoda et al. · Journal of Hepatology · 2016 · 147 citations · Full text

Medicine, Hematology, Oncology +9

Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis

Takashi Kumada, Hidenori Toyoda, Toshifumi Tada et al. · Journal of Hepatology · 2012 · 139 citations

Medicine, Oncology, Carcinogenesis +14

Prognostic Significance of Simultaneous Measurement of Three Tumor Markers in Patients With Hepatocellular Carcinoma

Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama et al. · Clinical Gastroenterology and Hepatology · 2006 · 110 citations · Full text

Medicine, Oncology, Pathology +17

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis <scp>C</scp> virus infection

Hidenori Toyoda, Takashi Kumada, Toshifumi Tada et al. · Journal of Gastroenterology and Hepatology · 2015 · 96 citations

Medicine, Infectious Diseases, Hepatology +13

Comparison of the Usefulness of Three Staging Systems for Hepatocellular Carcinoma (CLIP, BCLC, and JIS) in Japan

Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama et al. · The American Journal of Gastroenterology · 2005 · 81 citations

Medicine, Oncology, Pathology +16